| Application no. and date | 11741348.4 (espacenet) (Federated) (European Patent Register), 20110706 | | Patent/reg. no. and date | DK/EP 2590676, 20160817 | | Publication date | 20130515 | | Priority no. and date | US 361828 P, 20100706 | | EP pub. no. and date |
EP 2590676 20130515 | | Effective date | | | Applicant/owner | GlaxoSmithKline Biologicals SA, Rue de l'Institut 89
1330 Rixensart, BE | | Applicant ref. no. | 159954 | | Inventor | GEALL, Andrew, Novartis Vaccines And Diagnostics Inc.
PO Box 8097
Emeryville, CA 94662-8097, US,
MANDL, Christian, Novartis Vaccines And Diagnostics Inc.
PO Box 8097
Emeryville, CA 94662-8097, US,
O'HAGAN, Derek, Novartis Vaccines And Diagnostics Inc.
PO Box 8097
Emeryville, CA 94662-8097, US,
SINGH, Manmohan, Novartis Vaccines And Diagnostics Inc.
PO Box 8097
Emeryville, CA 94662-8097, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 39/155 (2006.01) | | Title | Virionlignende fremføringspartikler til selvreplikerende RNA-molekyler | | Int. application no. | US2011043103 | | Int. publication no. | WO2012006376 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
